53-79-2

Puromycin (NSC-3055) is an antibiotic protein synthesis inhibitor. It inhibits protein synthesis by binding to RNA. It also serves as an anticancer drug by suppressing the growth and metastasis in esophagus cancer cells by Akt phosphorylation. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis.

Puromycin-D3 is the deuterated form of Puromycin. Derived from the bacterium Streptomyces, Puromycin (T19978) belongs to the aminoglycoside class of antibiotics and acts as an inhibitor of protein synthesis.

Puromycin-D3 dihydrochloride is the deuterated form of Puromycin dihydrochloride. Puromycin dihydrochloride (T2219) (CL13900 dihydrochloride) functions as an aminonucleoside antibiotic that inhibits protein synthesis.

Puromycin dihydrochloride (CL13900 dihydrochloride) is a cinnamamide adenosine antibiotic and an inhibitor of protein synthesis. Puromycin dihydrochloride inhibits protein synthesis by binding to RNA and has antitumor and antitrypanosomal activity.